Nasdaq:US$18.03 (+0.20) | HKEX:HK$28.40 (+0.20) | AIM:£2.85 (+0.05)
Events, Circulars & Forms
Previous Article   |   Next Article
Event | 30 Mar 2017

R&D Briefing for Investors 2017

Introduction
The Future of Targeted Cancer Therapy In Lung Cancer
Post-POC Portfolio
Pre-POC Portfolio
Research Strategy
Transforming into a Fully Integrated Global Biopharma
 

Wed. Mar 29, 9:30am – South Place Hotel, London, UK
» Click here to watch a replay of the event, including a keynote from Susan Galbraith, SVP of Oncology iMed, AstraZeneca

 

Thu. Mar 30, 8:30am – W Hotel, New York, NY
» Click here to watch a webcast of the event

 

» See press release for a description of the event